CN101554445B - Traditional Chinese medicine for treating diabetic hyperlipemia - Google Patents

Traditional Chinese medicine for treating diabetic hyperlipemia Download PDF

Info

Publication number
CN101554445B
CN101554445B CN2008101035977A CN200810103597A CN101554445B CN 101554445 B CN101554445 B CN 101554445B CN 2008101035977 A CN2008101035977 A CN 2008101035977A CN 200810103597 A CN200810103597 A CN 200810103597A CN 101554445 B CN101554445 B CN 101554445B
Authority
CN
China
Prior art keywords
chinese medicine
radix
traditional chinese
portions
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008101035977A
Other languages
Chinese (zh)
Other versions
CN101554445A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wei Dezong
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2008101035977A priority Critical patent/CN101554445B/en
Publication of CN101554445A publication Critical patent/CN101554445A/en
Application granted granted Critical
Publication of CN101554445B publication Critical patent/CN101554445B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention belongs to the field of traditional Chinese medicines for treating hyperlipemia, provides a traditional Chinese medicine for treating diabetic hyperlipemia and aims at achieving favorable effect and quick response. The traditional Chinese medicine is prepared from sealwort, tuber fleeceflower root, glossy ganoderma, lycium bark, notoginseng, seaweed, kudzuvine root, Chinese angelica,virgate wormwood herb and other raw materials, has the functions of strengthening healthy energy, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, nourishi ng Yin and clearing heat, dissolving phlegm, generating favorable effect and quick response and has the advantages of marked effect, determined curative effect and quicker response.

Description

A kind of Chinese medicine for the treatment of diabetes hyperlipaemia
Technical field
The invention belongs to the field of Chinese medicines of treatment diabetes.
Background technology
The diabetics hypoimmunity, metabolism disorder, quite a few concurrent hyperlipemia.Treat the Chinese medicine aspect of diabetic hyperlipidemia at present, come with some shortcomings: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect, and patient and family members thereof are dissatisfied to this.
At the problem of above-mentioned proposition, the invention provides a kind of Chinese medicine for the treatment of diabetes hyperlipaemia, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
A kind of Chinese medicine for the treatment of diabetes hyperlipaemia adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Rhizoma Polygonati 0.4-3.6 part Radix Polygoni Multiflori 0.4-3.6 part Ganoderma 0.15-1 part
Cortex Lycii 0.2-1.8 part Radix Notoginseng 0.3-2.6 part Sargassum 0.15-1 part
Radix Puerariae 0.3-2.6 part Radix Angelicae Sinensis 0.4-3.6 part Herba Artemisiae Scopariae 0.3-2.6 part
The Chinese medicine of this treatment diabetes hyperlipaemia is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Polygonati, Radix Polygoni Multiflori, Cortex Lycii, Sargassum, Radix Puerariae, Radix Angelicae Sinensis, Herba Artemisiae Scopariae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science thinks that diabetic hyperlipidemia is a hypoimmunity, and the deficiency of YIN is scorching, and caused by energy stagnation and blood stasis is controlled when the body resistance strengthening and constitution consolidating, QI invigorating the moon, and is hot and suffocating clearly, the expectorant stasis of blood.The present invention's prescription, Ganoderma QI invigorating, the body resistance strengthening and constitution consolidating, tonification the five internal organs; Radix Angelicae Sinensis, Radix Notoginseng benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling; Rhizoma Polygonati, the nourishing the liver of Radix Polygoni Multiflori YIN nourishing, benefiting essence-blood all has the strengthening by means of tonics effect; 5 with Cortex Lycii, Radix Puerariae, Herba Artemisiae Scopariae, four antipyretic analgesicses of Sargassum, have his own strong points, and Cortex Lycii is analgesic, and removing heat from blood is removed blood fat reducing; Radix Puerariae is analgesic, and promoting the production of body fluid to quench thirst moistens passages through which vital energy circulates; Herba Artemisiae Scopariae is analgesic, the anti-expectorant of eliminating damp-heat; The Sargassum heat clearing away, clearing away dryness heat-phlegm fire has softening the hard mass, diuresis, blood coagulation resisting function.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, the merit of nourishing YIN and clearing away heat expectorant.Effective, instant effect has that effect is remarkable, drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, gets following prescription (weight is unit by gram)
Rhizoma Polygonati 55 gram Radix Polygoni Multiflori 55 kairine sesames 20 grams
Cortex Lycii 35 gram Radix Notoginseng 60 gram Sargassums 25 grams
Radix Puerariae 45 gram Radix Angelicae Sinensis 55 gram Herba Artemisiae Scopariaes 45 grams
Weight is extracted Rhizoma Polygonati, Radix Polygoni Multiflori, Cortex Lycii, Sargassum, Radix Puerariae, Radix Angelicae Sinensis, Herba Artemisiae Scopariae with conventional water extraction process in accordance with regulations, makes extract powder 94.5 grams; Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix with above-mentioned extractum fine powder, stir, make fine particle, the capsule of packing into No. 0 is made 623 of Chinese medicinal capsules.Every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram)
Rhizoma Polygonati 180 gram Radix Polygoni Multiflori 180 kairine sesames 60 grams
Cortex Lycii 90 gram Radix Notoginseng 130 gram Sargassums 60 grams
Radix Puerariae 130 gram Radix Angelicae Sinensis 180 gram Herba Artemisiae Scopariaes 130 grams
By above-mentioned same quadrat method, make 1696 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram)
Rhizoma Polygonati 360 gram Radix Polygoni Multiflori 360 kairine sesames 100 grams
Cortex Lycii 180 gram Radix Notoginseng 250 gram Sargassums 100 grams
Radix Puerariae 250 gram Radix Angelicae Sinensis 360 gram Herba Artemisiae Scopariaes 250 grams
By above-mentioned same quadrat method, make 3242 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight)
3.2 parts of 6.2 portions of Ganodermas of 6.2 parts of Radix Polygoni Multiflori of Rhizoma Polygonati
3.2 parts of 4.5 portions of Sargassums of 3.2 portions of Radix Notoginseng of Cortex Lycii
4.5 parts of 6.2 portions of Herba Artemisiae Scopariaes of 4.5 parts of Radix Angelicae Sinensis of Radix Puerariae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight)
10 parts of 35 portions of Ganodermas of 35 parts of Radix Polygoni Multiflori of Rhizoma Polygonati
10 parts of 25 portions of Sargassums of 16 portions of Radix Notoginseng of Cortex Lycii
25 parts of 35 portions of Herba Artemisiae Scopariaes of 25 parts of Radix Angelicae Sinensis of Radix Puerariae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science diabetes hyperlipaemia, through 16 routine clinical observations.Selecting the tcm diagnosis diabetes hyperlipaemia is standard: diabetics has a delicate constitution, limb adynamia, and the deficiency of YIN is scorching, the visible triglyceride>150mg/dl of blood count, T-CHOL>200mg/dl.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 9 examples, women's 7 examples do not have other serious disease, and the age is 37 years old---66 years old, 52.9 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong; The scorching obvious alleviation of the deficiency of YIN, total triglyceride, T-CHOL index are normal.
2, effective: body constitution strengthens, and the deficiency of YIN is scorching to be alleviated to some extent, and total triglyceride, T-CHOL descend to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Take Chinese medicinal capsule of the present invention, observing 3 months is a course of treatment.Instructions of taking: every day 3 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.16 philtrums of clinical experiment, produce effects 7 people, effective 8 people, invalid 1 people, total effective rate 93.7%.

Claims (1)

1. Chinese medicine for the treatment of diabetes hyperlipaemia, it is characterized in that: it is made with the component of following weight ratio, and its component proportioning is:
Rhizoma Polygonati 0.4---1 part of 3.6 parts of Radix Polygoni Multiflori 0.4---3.6 portions of Ganodermas 0.15---
Cortex Lycii 0.2---1 part of 1.8 portions of Radix Notoginseng 0.3---2.6 portions of Sargassums 0.15---
Radix Puerariae 0.3---2.6 parts of 2.6 parts of Radix Angelicae Sinensis 0.4---3.6 portions of Herba Artemisiae Scopariaes 0.3---
The Chinese medicine of this treatment diabetes hyperlipaemia is made by following method:
(1) by above-mentioned weight ratio, Rhizoma Polygonati, Radix Polygoni Multiflori, Cortex Lycii, Sargassum, Radix Puerariae, Radix Angelicae Sinensis and Herba Artemisiae Scopariae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Ganoderma, Radix Notoginseng are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill or Tabules.
CN2008101035977A 2008-04-09 2008-04-09 Traditional Chinese medicine for treating diabetic hyperlipemia Expired - Fee Related CN101554445B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008101035977A CN101554445B (en) 2008-04-09 2008-04-09 Traditional Chinese medicine for treating diabetic hyperlipemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008101035977A CN101554445B (en) 2008-04-09 2008-04-09 Traditional Chinese medicine for treating diabetic hyperlipemia

Publications (2)

Publication Number Publication Date
CN101554445A CN101554445A (en) 2009-10-14
CN101554445B true CN101554445B (en) 2010-12-15

Family

ID=41172827

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008101035977A Expired - Fee Related CN101554445B (en) 2008-04-09 2008-04-09 Traditional Chinese medicine for treating diabetic hyperlipemia

Country Status (1)

Country Link
CN (1) CN101554445B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105533758A (en) * 2015-12-21 2016-05-04 青岛浩大海洋保健食品有限公司 Seaweed protein healthcare capsule with blood sugar-reducing function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249939A (en) * 1998-10-05 2000-04-12 王平 Hyperlipemia treating bolus
CN101095753A (en) * 2007-07-05 2008-01-02 北京艺信堂医药研究所 Chinese medicine preparation for treating diabetic hyperlipaemia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249939A (en) * 1998-10-05 2000-04-12 王平 Hyperlipemia treating bolus
CN101095753A (en) * 2007-07-05 2008-01-02 北京艺信堂医药研究所 Chinese medicine preparation for treating diabetic hyperlipaemia

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
梁晓春.中医中药治疗糖尿病高脂血症研究进展.《中国中西医结合急救杂志》.2007,第14卷(第4期),254-256. *
楼锦英.中药降脂研究现状.《浙江中医学院学报》.2002,第26卷(第5期),79-80. *
江伟,陈少卿.活血益气补肾汤治疗2型糖尿病高脂血症34例.《陕西中医》.2007,第28 卷(第6期),679-681. *

Also Published As

Publication number Publication date
CN101554445A (en) 2009-10-14

Similar Documents

Publication Publication Date Title
CN101530515B (en) Traditional Chinese medicine for treating diabetes mellitus complicated by intumescent prostate
CN101390993B (en) Traditional Chinese medicine for treating diabetic foot
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101554445B (en) Traditional Chinese medicine for treating diabetic hyperlipemia
CN101530593B (en) Traditional Chinese medicine for treating diabetic numbness of extremities
CN101843778B (en) Chinese medicament for treating ichthyosis
CN101537121B (en) Chinese medicine for treating arteriosclerosis
CN101554426B (en) Traditional Chinese medicine for treating diabetic obstipation
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101843733A (en) Chinese medicament for treating ichthyosis
CN101518622B (en) Traditional Chinese medicine for treating diabetes complicated with urinary infection
CN101843864A (en) Chinese medicament for treating diabetic acro-necrosis
CN101843771B (en) Chinese medicament for treating ichthyosis
CN101530501B (en) Traditional Chinese medicine for treating diabetic anemia
CN101554418B (en) Traditional Chinese medicine for treating diabetic peripheral neuritis
CN101843756B (en) Chinese medicament for treating chronic nephritis
CN101879259B (en) Traditional Chinese medicine for treating pulmonary heart diseases
CN101843844B (en) Chinese medicament for treating pulmonary heart diseases
CN101843808B (en) Chinese medicament for treating ichthyosis
CN101843871B (en) Chinese medicament for treating diabetic acro-necrosis
CN101843809A (en) Chinese medicament for treating ichthyosis
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases
CN101396454A (en) Traditional Chinese medicine for treating diabetic skin pruritus

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WEI DEZONG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION

TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui

Patentee after: Wei Dezong

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101215

Termination date: 20170409